Free Submission Public Relations &
Deutsch English


Lung Transplantation - Pipeline Review, H1 2013 - New Study Released

Print article Print article
2013-03-31 09:20:40 - Fast Market Research recommends "Lung Transplantation - Pipeline Review, H1 2013" from Global Markets Direct, now available

Global Markets Direct's, 'Lung Transplantation - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Lung Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lung Transplantation. Lung Transplantation - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated


Full Report Details at
- ..


* A snapshot of the global therapeutic scenario for Lung Transplantation.
* A review of the Lung Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Lung Transplantation pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Lung Transplantation.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Lung Transplantation pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Lung Transplantation Overview
Therapeutics Development
An Overview of Pipeline Products for Lung Transplantation
Lung Transplantation Therapeutics under Development by Companies
Lung Transplantation Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Lung Transplantation Therapeutics - Products under Development by Companies
Lung Transplantation Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Lung Transplantation Therapeutics Development
Quark Pharmaceuticals, Inc.
Vectura Group plc
Proteo, Inc.
APT Pharmaceuticals, Inc.
Lung Transplantation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Elafin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
cyclosporine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Respiratory And Inflammatory Diseases Program - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VR-909 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Autologous Mesenchymal Stem Cells Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lung Transplantation Therapeutics - Drug Profile Updates
Lung Transplantation - Product Development Milestones
Featured News & Press Releases
Dec 06, 2011: Proteo And Its Subsidiary Announce Major Advances In Elafin Development Program
May 16, 2011: Chugai Pharma Files Application Seeking Japanese Approval For Pediatric Dosage And Administration Of CellCept
Feb 11, 2010: PARI Pharma Enrolls First Patient In Phase IIb Study Of L-CsA
Sep 08, 2009: APEPTICO Presents Lead Product AP301 At Annual Congress Of European Respiratory Society In Vienna, Austria
Jun 02, 2009: PARI Pharma Reports Successful Phase Ib Clinical Results For Inhaled Liposomal Cyclosporine A And Gains FDA Orphan Drug Designation For The Prevention And Treatment Of Bronchiolitis Obliterans
Secondary Research
Primary Research
Expert Panel Validation
Contact Us

List of Tables
Number of Products Under Development for Lung Transplantation, H1 2013
Products under Development for Lung Transplantation - Comparative Analysis, H1 2013
Number of Products under Development by Companies, H1 2013
Number of Products under Investigation by Universities/Institutes, H1 2013
Comparative Analysis by Late Stage Development, H1 2013
Comparative Analysis by Early Clinical Stage Development, H1 2013
Comparative Analysis by Pre-Clinical Stage Development, H1 2013
Products under Development by Companies, H1 2013
Products under Investigation by Universities/Institutes, H1 2013
Quark Pharmaceuticals, Inc., H1 2013
Vectura Group plc, H1 2013
Proteo, Inc., H1 2013

Full Table of Contents is available at:

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact